The PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor demonstrates wound healing potential. It helps users to analyze patients with wounds in their lower extremities.
Users can assess the microcirculation of the patient’s limbs using a transcutaneous measurement of oxygen from the tissue.
A transcutaneous monitoring solution with reproducible TCOM test protocols
There are numerous test regimens for the transcutaneous monitor. The preloaded transcutaneous oxygen measuring (TCOM) test protocols ensure reproducibility of measurement of the patient and across teams..
From patient preparation to the various steps of measurement, the instructions presented on the touch screen interface assist users through each step. The tiny and portable stand-alone monitor can be taken anywhere. If necessary, it can even be placed on a stand or a cart.
Image Credit: Radiometer Medical
Transcutaneous monitor with eight TCOM sensors
Up to eight tcpO2 sensors are included in the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor.
This gives a more comprehensive view of the wound’s surroundings. It helps to speed up the measurement process and obtain a more precise map of the extremity.
With the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor, utilize Radiometer E5250 tcpO2 sensors. Users can acquire important data from the sensors to assess patients with peripheral artery disease.
Image Credit: Radiometer Medical
Streamlined data capture
A camera is included in the transcutaneous monitor for TCOM documentation. Users can obtain a layout of the sensors surrounding the wound area in addition to tcpO2 measurements.
Users will also get an automatically generated report with patient data, TCOM values and a picture of the sensors’ placements surrounding the incision. The field entries included in the report can be customized and it can be personalized by adding in the hospital’s logo.
Image Credit: Radiometer Medical
Patient data integrity
Password protection is available for the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor. It is possible to encrypt the hard disk as well. The audit trail keeps track of who uses the monitor and what they do.
These features assist in meeting the regulatory obligations. Additionally, users can also improve the security of important patient data.
The Health Insurance Portability and Accountability Act (HIPAA) is applicable to the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor. Perimed AB has connectivity options for the PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor.